Related references
Note: Only part of the references are listed.A modified clot-based assay to measure negatively charged procoagulant phospholipids
Cathrine Ramberg et al.
SCIENTIFIC REPORTS (2021)
Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial
Suzanne Schol-Gelok et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis
Marta Zara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
Fernanda A. Orsi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Rosuvastatin use improvesmeasures of coagulation in patients with venous thrombosis
Joseph S. Biedermann et al.
EUROPEAN HEART JOURNAL (2018)
Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis
Simin Jamaly et al.
SCIENTIFIC REPORTS (2018)
Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies
Setor K. Kunutsor et al.
EUROPEAN HEART JOURNAL (2017)
Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis
Setor K. Kunutsor et al.
LANCET HAEMATOLOGY (2017)
The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles
Justyna Rosinska et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
The association of statin therapy with the risk of recurrent venous thrombosis
N. L. Smith et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial
J. S. Biedermann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study
C. Martinez et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
The epidemiology of venous thromboembolism
John A. Heit et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S
Elena Campello et al.
THROMBOSIS AND HAEMOSTASIS (2016)
The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke
Malgorzata Pawelczyk et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
Venous thrombosis
Alisa S. Wolberg et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
Jan Beyer-Westendorf et al.
BLOOD (2014)
Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study
M. Schmidt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Circulating microparticles in carriers of prothrombin G20210A mutation
Elena Campello et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Procoagulant and platelet-derived microvesicle absolute counts determined by flow cytometry correlates with a measurement of their functional capacity
Lisa Ayers et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
Statin treatment and the risk of recurrent pulmonary embolism
Sara Biere-Rafi et al.
EUROPEAN HEART JOURNAL (2013)
Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells
Rosa Suades et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Pharmacokinetic interactions between clopidogrel and rosuvastatin: Effects on vascular protection in subjects with coronary heart disease
Luiz F. Pinheiro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Statins but Not Aspirin Reduce Thrombotic Risk Assessed by Thrombin Generation in Diabetic Patients without Cardiovascular Events: The RATIONAL Trial
Alejandro Macchia et al.
PLOS ONE (2012)
Platelet-Derived Microvesicles: Multitalented Participants in Intercellular Communication
Maria Aatonen et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis
Elena Campello et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials
Kazem Rahimi et al.
PLOS MEDICINE (2012)
Microparticles in Hemostasis and Thrombosis
A. Phillip Owens et al.
CIRCULATION RESEARCH (2011)
Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease
Fariborz Mobarrez et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Statins in the prevention of venous thromboembolism: A meta-analysis of observational studies
Menaka Pai et al.
THROMBOSIS RESEARCH (2011)
Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism
B. A. L. Owen et al.
THROMBOSIS RESEARCH (2011)
Circulating procoagulant microparticles in acute pulmonary embolism: A case-control study
Laurence Bal et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT
David E. Connor et al.
BLOOD COAGULATION & FIBRINOLYSIS (2009)
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Robert J. Glynn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Circulating procoagulant microparticles in patients with venous thromboembolism
Cihan Ay et al.
THROMBOSIS RESEARCH (2009)
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
Paolo Prandoni et al.
HAEMATOLOGICA (2007)
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Duration of anticoagulation following venous thrombolembolism - A meta-analysis
D Ost et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes
DW Sommeijer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism
NJGM Veeger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Losartan and simvastatin inhibit platelet activation in hypertensive patients
S Nomura et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2005)
The epidemiology of venous thromboembolism
RH White
CIRCULATION (2003)
Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components
AU Ural et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Predictors of recurrence after deep vein thrombosis and pulmonary embolism -: A population-based cohort study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
